ATE136469T1 - Neue verwendung eines monoklonalen antikörpers - Google Patents

Neue verwendung eines monoklonalen antikörpers

Info

Publication number
ATE136469T1
ATE136469T1 AT91914884T AT91914884T ATE136469T1 AT E136469 T1 ATE136469 T1 AT E136469T1 AT 91914884 T AT91914884 T AT 91914884T AT 91914884 T AT91914884 T AT 91914884T AT E136469 T1 ATE136469 T1 AT E136469T1
Authority
AT
Austria
Prior art keywords
monoclonal antibody
new use
specificity
fragments
variants
Prior art date
Application number
AT91914884T
Other languages
English (en)
Inventor
Hans Loibner
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Application granted granted Critical
Publication of ATE136469T1 publication Critical patent/ATE136469T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91914884T 1990-08-11 1991-08-08 Neue verwendung eines monoklonalen antikörpers ATE136469T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen

Publications (1)

Publication Number Publication Date
ATE136469T1 true ATE136469T1 (de) 1996-04-15

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91914884T ATE136469T1 (de) 1990-08-11 1991-08-08 Neue verwendung eines monoklonalen antikörpers

Country Status (13)

Country Link
EP (1) EP0547079B1 (de)
JP (1) JPH06500771A (de)
KR (1) KR930701193A (de)
AT (1) ATE136469T1 (de)
AU (1) AU657489B2 (de)
CA (1) CA2088370C (de)
DE (2) DE4025499A1 (de)
HU (1) HUT64238A (de)
IE (1) IE912823A1 (de)
PT (1) PT98622A (de)
TW (1) TW223019B (de)
WO (1) WO1992003165A1 (de)
ZA (1) ZA916313B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2145004T3 (es) * 1991-08-21 2000-07-01 Novartis Ag Derivados de anticuerpos.
NZ252161A (en) * 1992-05-22 1996-10-28 Sandoz Ltd Monoclonal murine internal image anti-idiotypic antibodies (ab2) to monoclonal antibodies br55 (ab1), their production and use in immunizing against hiv and epithelial and lung cancers
JP2002519334A (ja) * 1998-06-29 2002-07-02 ベルクター，ヴォルフガンク αエミッタとβエミッタとを主成分とする抗ウイルスおよび抗レトロウイルス放射免疫薬剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット

Also Published As

Publication number Publication date
HUT64238A (en) 1993-12-28
DE4025499A1 (de) 1992-02-13
HU9300349D0 (en) 1993-05-28
ZA916313B (en) 1993-04-28
JPH06500771A (ja) 1994-01-27
CA2088370C (en) 2003-03-25
IE912823A1 (en) 1992-02-12
EP0547079B1 (de) 1996-04-10
PT98622A (pt) 1992-06-30
DE69118702T2 (de) 1996-09-05
AU657489B2 (en) 1995-03-16
KR930701193A (ko) 1993-06-11
TW223019B (de) 1994-05-01
WO1992003165A1 (en) 1992-03-05
AU8393291A (en) 1992-03-17
EP0547079A1 (de) 1993-06-23
DE69118702D1 (de) 1996-05-15
CA2088370A1 (en) 1992-02-12

Similar Documents

Publication Publication Date Title
DE69109642D1 (de) Anpassungsfähige Formgebung von Verbundwerkstoffen.
BR9707049A (pt) Agentes anticoagulantes utilizáveis no tratamento de trombose
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
AR001811A1 (es) Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones
DE3783277D1 (de) Monoklonaler antikoerper gegen humanes lungenkarzinom.
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
FI915564A7 (fi) Torkparti.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
IT8721678A0 (it) Anticorpi monoclonali e peptidi utili a trattare e diagnosticare infezioni da hiv.
FI931393A0 (fi) Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
EP0618930A4 (en) Monoclonal antibody to hiv-2 and uses thereof.
FI973484A0 (fi) Menetelmä immuunivasteen stimuloimiseksi
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
DE69841331D1 (de) Humanisierte monoklonale antikörper die schützen gegen shigatoxininduzierte krankheiten
DE69118702D1 (de) Neue verwendung eines monoklonalen antikörpers
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
DK0583281T3 (da) Modgift - immunsera
DE3485965D1 (de) Monoklonaler antikoerper mit spezifitaet gegen nur einen typ eines isozyms der schweren kette des menschlichen herzmyosins.
DE69129582D1 (de) Antikörper gegen menschlichen plasmin-alpha 2-plasmininhibitor-komplex, hybridoma und immunoassay
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
NO902620D0 (no) Drivstoff og brenselbehandling.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties